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Vitamin A supplements in newborns and child survival
Benefit depends on the setting, baseline infant mortality, and vitamin A deficiency
Vitamin A supplementation at 6-72 months of age has 
become a mainline intervention for improving survival 
in populations with endemic vitamin A deficiency.1 
However, in the same setting, supplementation at 
1-6 months of age has little or no effect on mortality, 
whether given with immunisation or not.2 3
Giving vitamin A supplements to newborns within 
the first few days of life significantly reduced early 
infant mortality in Asian populations with endemic 
maternal vitamin A deficiency and high infant mortal-
ity.4-6 In Africa, however, this strategy had no benefi-
cial effect on early infant survival in an urban setting7 
or—as reported in the accompanying paper by Benn 
and colleagues—in a peri-urban setting.8 
How can these findings be reconciled? A meta-analysis 
of all the newborn dosing studies might provide a more 
accurate estimate of the true effect on early infant mortal-
ity. But combining these studies would be a fundamental 
mistake, because the variation in effect on early infant 
mortality in the five available studies is what would 
be expected given the variations in the  populations 
included.
So how can the variation in outcomes be explained? 
Differences between the study populations are key. 
Vitamin A supplements have the greatest benefit in 
populations with high mortality and endemic vitamin 
A deficiency. Deaths from causes (such as infectious 
diseases) that are most likely to be affected by vitamin 
A supplements will already be low in populations with 
low mortality. Also, if a population is already receiving 
sufficient vitamin A from dietary sources, supplements 
are unlikely to improve vitamin A status enough to 
decrease death from infectious diseases.
So, which of the five studies of vitamin A dosing in 
newborns were conducted in populations with high 
infant mortality and endemic vitamin A deficiency? The 
studies in India and Bangladesh were done in popula-
tions with high infant mortality.5 6 In these studies, rates 
of maternal night blindness in pregnancy were high 
enough to classify vitamin A deficiency as being of pub-
lic health importance.6 9 In contrast, both African studies 
were done in populations with little, if any, vitamin A 
deficiency; mortality in the Zimbabwean study was very 
low7; and the study in Guinea-Bissau reduced mortality 
by excluding the highest risk infants (those with low birth 
weight) and giving free care and drugs to sick infants.8
Vitamin A status in newborns is difficult to interpret 
because all infants are born with low reserves of vita-
min A, especially those born prematurely. Newborns 
depend on adequate supplies from breast milk or 
appropriate substitutes to satisfy physiological demands 
in early life.10 The risk of vitamin A deficiency in these 
cases should be judged by the status of the mothers, not 
the infants. Despite Benn and colleagues’ claim that dif-
ferences in the characteristics of the study populations 
cannot explain the variation in treatment effects, they 
are the most likely explanation.
The outlier study in this assessment is the Indone-
sian study, the smallest of the five studies. It found 
that giving vitamin A supplements to newborns had a 
large effect on early infant mortality, even though the 
mothers’ serum retinol concentrations were relatively 
normal.4 But vitamin A deficiency is a common prob-
lem in women and children in Indonesia,11 and liver 
reserves may have been low even though serum retinol 
concentrations were adequate; alternatively, the find-
ing in Indonesia may have been the result of chance.
Benn and colleagues’ study provides no new infor-
mation on the interactions between vitamin A supple-
ments and vaccines as all children received concurrent 
BCG and, we assume, the other standard vaccines 
including diphtheria, pertussis, and tetanus; oral polio; 
hepatitis B; and measles vaccines. Observational evi-
dence suggests that giving vitamin A supplements to 
infants may modify the effect of vaccines on early 
infant mortality.12 However, little is likely to be gained 
from further observational data as the selection bias 
associated with the receipt of vaccines is almost impos-
sible to overcome. Further delineating this interaction 
will require randomised trials of both newborn vita-
min A supplementation and immunisation, which are 
unlikely given current immunisation policies.
Still missing from the evidence base are trials from 
populations in sub-Saharan Africa with endemic vita-
min A deficiency and high infant mortality. Such popu-
lations exist in areas of eastern and southern Africa, and 
trials in these areas are urgently needed. Also, we still 
do not know why vitamin A supplements are beneficial 
when given in the first few days of life, at least in Asia, 
but have no effect on mortality when given only a few 
weeks later at the time of the first diphtheria, pertus-
sis, and tetanus immunisation. Studies exploring the 
mechanisms of action of early versus later supplementa-
tion would be helpful.
Given current evidence, Benn and colleagues’ con-
clusion that “a global or regional recommendation 
of 50 000 IU vitamin A supplementation at birth is 
unwarranted” is untenable. For populations in Asia 
who are deficient in vitamin A the evidence for benefit 
is convincing. Recommendations for Africa await the 
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Risk factors for gastroschisis
Genitourinary infection in early pregnancy can be added to the existing list
Gastroschisis is a small abdominal fissure lateral to an 
intact umbilical cord, generally to the right. The bowel 
herniates throughout the fissure and is not covered by 
membrane. Unlike most other birth defects, reported 
rates of gastroschisis have increased over the past 25 
years from 0.1-1.0 per 10 000 births to 3.0-5.0 per 10 000 
births in many developed and developing countries, 
with the notable exception of Italy, where rates have 
remained stable at under 1.0 per 10 000.1-3 In the linked 
study, Feldkamp and colleagues assess whether geni-
tourinary infections increased the risk for gastroschisis 
in participants in the national birth defects prevention 
study (NBDPS).4 
Research on risk factors has previously been ham-
pered by the relative rarity of the defect and by unclear 
case definition. For example, the ICD-9 (international 
classification of diseases, 9th revision) coding system 
combined omphalocele and gastroschisis under a 
 single code (756.7). Moreover, the pathogenesis and the 
 embryological period during which the defect develops 
are still unclear. The debate about whether gastroschisis 
is a disruption occurring after the formation of the 
 abdominal wall or a primary malformation of the folding 
process of the abdominal wall has recently reopened.5
Nevertheless, one consistent risk factor has been 
shown in all epidemiological studies, young maternal 
age. One European study found that compared with 
mothers aged 25-29, the relative risk was 7.0 (95% 
 confidence interval 5.6 to 8.7) for mothers under 20 
and 2.4 (2.0 to 3.0) for mothers aged 20-24 years.3 
The correlation with young maternal age suggests that 
 environmental factors are involved.
In their case-control study, Feldkamp and colleagues 
assess the association between gastroschisis and geni-
tourinary infection from one month before conception 
through to the end of the first trimester.4 Diagnosis was 
by expert review of all cases in live born infants, still-
births, and terminations of pregnancy. The study uses 
a computer assisted telephone interview in English or 
Spanish as part of an ongoing population based study 
funded by the Centers for Disease Control and Preven-
tion, which includes 10 state run surveillance systems of 
birth defects in the United States. A genitourinary infec-
tion was self reported by 16.2% of women with affected 
infants (n=505) and 8.7% of mothers of healthy live born 
infants (n=4924). The resulting odds ratio—adjusted for 
maternal age, body mass index before conception, 
smoking, and Hispanic ethnicity (a specific genetic back-
ground and suggestive of a low socioeconomic status)—
was 1.5 (1.1 to 1.9).
The study is important not only because it highlights 
genitourinary infection as a new risk factor for gastro-
schisis, but also because the risk factors used in the logis-
tic model to compute adjusted odds ratios were found to 
be important in previous studies.6 For example, a recent 
large population based case-control study in the United 
Kingdom found significant adjusted odds ratios for the 
use of aspirin (20.4), use of vasoconstrictive recreational 
drugs (ecstasy, amphetamine, and cocaine) (3.3), history 
of gynaecological infection (2.6), use of any recreational 
drug (2.2), low body mass index (2.0), unmarried status 
(1.8), and cigarette smoking (1.7).7 If the associations 
are causal, the highest population attributable risk is for 
cigarette smoking (28%); this information is useful for 
promoting preventive action.
Other case-control studies have indicated that hav-
ing at least two children, each from a different father, is 
a further risk factor.8 An increased risk of gastroschisis 
has been reported in women who smoke cigarettes or 
marijuana (26.5, 7.9 to 89.4) and women with a low body 
mass index.9 An interaction between smoking and gene 
polymorphisms (ICAM-1 gly241arg, NOS3 glu298asp, 
NPPA T22238C) has also been  suggested.10
The overall pattern of findings from all of these 
studies suggests that the risk for having an infant 
with  gastroschisis is highest in young women, mainly 
 teenagers, with one or more of the following char-
acteristics—have low socioeconomic status, smoke 
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cigarettes, eat too little, drink alcohol, use illicit drugs, 
have early and  unprotected sexual intercourse, and 
have genitourinary infection.
These risk factors—perhaps in combination with 
genetic susceptibility—may explain the link between 
low maternal age and increased frequency of the 
defect in many countries. But to explain the  threefold 
to fivefold increase seen in many countries in the 
past few decades, several risk factors must strongly 
interact.
The study by Feldkamp and colleagues provides an 
opportunity to evaluate the current interacting web of 
risk factors.4 Moreover, it is interesting that 43% of moth-
ers with affected infants reported a Chlamydia trachomatis 
infection because this infection has many common risk 
factors with gastroschisis, plus it can be screened for and 
treated.11 Ascertaining a history of C trachomatis infection 
should be considered in future studies.
In the meantime, preventive actions to reduce the 
 frequency of gastroschisis worldwide must be considered 
and urgently implemented. Global reproductive health 
counselling, which involves several preventive actions 
tailored to the needs of adolescents and young women, 
is the best approach to deal with the complex biomedical 
and sociocultural set of risk  factors.12 
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Wheeze in preschool children
exercise induced wheeze and atopic disorders predict persistent asthma
Wheeze is an increasingly common symptom in pre-
school children. In Leicestershire, the proportion of 
children aged less than 5 years who had ever wheezed 
rose from 16% in 1990 to 29% in 1998.1 Wheezing ill-
ness is therefore a common source of anxiety to parents 
and professionals involved in the care of young chil-
dren, all of whom would like an accurate diagnosis and 
prognosis. In the accompanying study, Frank and col-
leagues report the long term outcome of 628 children 
with and without preschool wheeze, including factors 
that predict asthma in later life.2
Many different wheeze phenotypes have been 
described in this age group.3 4 Most children will 
 eventually turn out to have been “transient early 
 wheezers.” These children do not usually have a fam-
ily history or personal history of atopy, and the wheeze 
tends to settle by the age of 3 years. A second group of 
children with transient symptoms consists of “non-atopic 
wheezers,” most of whom settle by the age of 5 years, 
although the syndrome can persist well into school age 
years (figure).5
These two groups overlap considerably; infection is 
the main precipitant of wheeze in both, so they are often 
lumped together as having “virus associated wheeze” or 
“wheezy bronchitis.” These two groups can be distin-
guished by pulmonary function measurements—the tran-
sient early wheezers have relatively narrow airways that 
are readily obstructed by the minor degree of mucosal 
inflammation that accompanies upper respiratory tract 
infection, whereas the non-atopic wheezers show bron-
chial hyper-reactivity to methacholine.4 These assess-
ments are unlikely to be available to clinicians working 
outside tertiary centres, however.
A third group—“IgE associated wheeze”—is important 
because wheeze tends to persist in these children and 
a diagnosis of asthma can reasonably be offered. It is 
defined in terms of objective measures of atopy—that is, 
raised IgE concentrations, positive radioallergosorbent 
tests, or positive skin prick tests.4 This type of wheeze is 
also associated with evidence of airway inflammation in 
the form of raised exhaled nitric oxide concentrations.6
Faced with a wheezing toddler or infant, what 
should clinicians do? Firstly, it must be established 
that wheeze is actually present. The public’s under-
standing of the term wheeze seems to have changed. 
This term should be reserved for whistling noises, 
but it is now being used to describe various vibratory 
phenomena.7 Mindful of these problems, in a birth 
cohort study in Aberdeen, we identified 210 parents 
who described their 2 year old children as having 
wheezed; of these, only 24 (11%) defined this wheeze 
as whistling in character, the others described it as a 
rattling or purring noise.8 Parental use of the word 
wheeze must therefore be viewed with suspicion.
Parents will have little interest in the taxonomy of 
wheezing disorders but will want to know about treat-
ment and prognosis. In terms of treatment, the efficacy 
of β2 agonists during infancy is still unclear,9 but they are 
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generally effective in older children, particularly if given 
by means of a holding chamber (spacer) and mask.10 
Inhaled corticosteroids are of little benefit in intermit-
tent virus associated wheeze and are best reserved for 
children with more frequent or severe symptoms, par-
ticularly if there is a personal or family history of other 
atopic disorders, positive skin prick tests, or biochemical 
evidence of atopy.11 12
Until now it has been difficult to provide prognostic 
information on individual children, but Frank and col-
leagues’ study helps by assessing the predictive value of 
simple clinical data rather than complex immunological 
and physiological tests.2 The authors examined several 
factors that might influence the prognosis of wheeze in 
early childhood. Surprisingly, the severity and frequency 
of symptoms were unrelated to the persistence of symp-
toms. In contrast, a history of exercise induced wheeze—a 
clinical manifestation of bronchial hyper-reactivity—and 
a history of atopic disorders strongly predicted persist-
ence (exercise: odds ratio 4.44, 95% confidence interval 
1.94 to 10.13; atopy: 3.94, 1.72 to 9.00). These findings 
support the traditional view that asthma is essentially the 
occurrence of these two traits in the same person.
Obviously, it could be argued that these results are 
exactly what might have been anticipated—the more it 
looks like asthma, the more likely it is to be asthma—but 
most clinicians would probably have expected the fre-
quency and severity of attacks to have had some bearing 
on prognosis. This study therefore provides the  clinician 
with a simple approach to prognosis in the wheezy pre-
school child using information that is easily acquired at 
the bedside or in the consulting room. Nevertheless, the 
confidence intervals  surrounding these adjusted odds 
ratios are quite wide (and in the case of male sex include 
unity), so the approach should be used as a guide rather 
than a formula for certainty. 
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UK Child Safety Week will be launched by the Child 
Accident Prevention Trust on 23 June this year. Its 
aim is to raise awareness of childhood accidents and 
prevention strategies. 
Unintentional injury accounts for around one in 
five of all deaths in children and adolescents in the 
European Union with the highest injury rates occur-
ring in Greece, Estonia, and Belgium.1 In the United 
Kingdom, unintentional injury is a leading cause of 
death and illness in chidren and is the most common 
cause of hospital admission—it accounts for around 
two million visits to accident and emergency depart-
ments each year, at a cost to the NHS of around 
£146m (€182m; $288m).2 Injury in childhood is 
strongly associated with poverty, and death rates 
from unintentional injury in the UK are around three 
times higher in children from the poorest families 
than in those from the least poor families; little is 
known about this topic in other countries.3-5 Children 
of parents in the UK who have never worked or who 
are long term unemployed are 13 times more likely 
to die from unintentional injury and are 37 times 
more likely to die as a result of exposure to smoke 
and fire than children of parents with higher manage-
rial and professional jobs.2
Most injury is avoidable. For example, if Scotland 
matched Sweden in death rates for children and 
 adolescents from unintentional injury then 62 lives 
a year—more than 40% of the total lives lost—would 
be saved.1
Injury surveillance systems are essential for  monitoring 
risk and developing and evaluating  community based 
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initiatives aimed at preventing injury in  children. 
They can motivate policy makers and communities to 
 participate in prevention activities.6 However, like many 
countries in Europe, the UK has no  comprehensive 
 surveillance system for documenting childhood injury, 
so the causes, risk factors, and short term and long term 
consequences of injury are unknown. This hinders 
development and implementation of  evidence based 
strategies to prevent injury.
The Audit Commission, Healthcare Commission, 
and the European Child Safety Alliance have criti-
cised the fragmented nature of injury policy in the 
UK and the lack of progress in setting up geographi-
cal population based surveillance systems. The UK 
Department of Trade and Industry’s surveillance 
system of accidents at home and leisure (based on 
hospital samples) was discontinued in 2002. Wales is 
the only UK country that routinely surveys injuries 
in children in accident and emergency departments 
using the All Wales Injury Surveillance System.7 Scot-
land is the only UK member of the “EuroSafe” Child 
Safety Action Plan project under the European Com-
mission’s Public Health Programme, which aims to 
“enhance child and adolescent safety by increasing 
awareness of the injury issue and uptake of proven 
prevention strategies.” However despite the pioneer-
ing work of the Information Services Division (NHS 
Scotland), which has incorporated the World Health 
Organization’s international classification of external 
causes of injuries into the National Clinical Data-
set Development Programme, Scotland has yet to 
identify the resources to develop and implement a 
surveillance system in NHS accident and emergency 
departments.
Part of the difficulty is that responsibility for chil-
dren is shared across numerous sectors and agen-
cies. So what should be done? The Accidental Injury 
Task Force, which advised the chief medical officer 
in England on how to reduce the rates of death and 
serious injury from accidents, recommended that 
public health observatories and their counterparts 
in local government should play a key role in injury 
surveillance. The public health observatories have 
established a virtual Injury Observatory of Britain 
and Ireland—which acts as a central resource for data 
on injuries, prevention strategies, and collaborative 
work—but little political support exists to develop the 
surveillance systems required to monitor childhood 
injury at country level.
Around one in five non-fatal unintentional injuries 
in children result from sport or recreational activities 
and almost a third occur in places used for sport, 
play, or recreation.8 The government hopes that the 
billions of pounds being invested in the 2012 Olym-
pics and  paraolympics will help reverse the decline 
in physical activity and fitness and the high levels of 
childhood obesity. However, the benefits have to be 
weighed against the risks—more than half the benefits 
of physical exercise may be lost through injuries, 
which can result in sports activity being abandoned 
completely.9
Injury surveillance systems and prevention strate-
gies could be used to help children participate in 
“safe” sport and reduce inequalities in rates of injury 
across social classes. Sweden, the Netherlands, and 
Denmark have developed well established  population 
injury surveillance systems to inform intervention 
and prevention strategies.10 All three countries have 
the lowest mortality from unintentional injury in chil-
dren and adolescents in Europe1 and high levels of 
participation in sport—Sweden has the highest rate of 
participation in Europe and half the levels of obesity 
seen in the UK.11 12
For UK governments to improve the health and 
wellbeing of children and to reduce inequalities, 
much more is needed. The creation of a UK all 
party parliamentary group to champion the cause of 
accident prevention is a small beginning. UK Gov-
ernments must now find the resources to develop 
population based injury surveillance systems so that 
the true incidence, causes, risk factors, and long term 
sequelae of injuries can be used to inform evidence 
based intervention.
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Next week, health ministers from all 53 member states 
of the World Health Organization’s European Region 
will meet in Tallinn to agree on a new charter. The first 
pan-European charter on health systems—signed in 
Ljubljana in 1989—focused on the purpose, goals, and 
core values of health systems. The Tallinn charter is 
more ambitious. Its aim is to spur political recognition 
of the economic case for investing in health systems, 
and to promote more effective stewardship of health 
resources by governments.
Expenditure on health services is still widely 
viewed as a short term cost, but substantial evidence 
now exists that it can benefit the economy. According 
to WHO, increasing life expectancy at birth by 10% 
increases economic growth by 0.35% each year.1 The 
view that health and wealth go together was also at 
the heart of the Wanless report, which argued that 
putting a high priority on disease prevention and 
effective early treatment would reduce future health-
care costs.2 Former European Union Commissioner 
for Health and Consumer Protection, David Byrne, 
argued for positioning health as a driver of economic 
development—an approach reflected in the new EU 
health strategy.3 A similar case has been made for 
eastern Europe and central Asia.4 Globally, the Com-
mission on Social Determinants of Health, whose 
final report will appear this summer, has stated that 
good health enables people to participate in society, 
with potentially positive consequences for economic 
performance.5
Not all countries accept the case for investing in 
health. This is particularly true among those European 
countries with the poorest health statistics. Dispari-
ties in wealth and health within the WHO European 
Region are wide. WHO data from 2004 showed that 
gross domestic product per capita ranged from less 
than $2000 (£1000; €1300) in Tajikistan to over 
$35 000 in Norway, and that the percentage of total 
government spending allocated to health varied from 
about 4% to18%. Inequalities in mortality may be 
small in some southern European countries, but they 
are large in most countries in the eastern and Baltic 
regions.6 Within Europe, the United Kingdom’s record 
is not one to be proud of. Life expectancy of men in 
one of the most deprived areas of Glasgow is 54 years 
compared with 82 years in the most affluent areas 
of the town.7 Furthermore, inequalities in health are 
continuing to grow across Europe.8
Increased investment in health will pay dividends 
only if it is well spent. The charter underlines the 
notion that governments must improve transparency 
and accountability for health spending and ensure 
that spending is aligned effectively to agreed policy 
objectives. Much hangs on the nature of these poli-
cies. According to experts from the WHO European 
Office, some of Europe’s poorer countries—including 
Moldova and Kyrgyzstan—have tackled inefficiencies 
in Soviet era systems they inherited, which has in turn 
enabled them to improve the coverage and quality 
of their health  services. Others—including Armenia, 
Azerbaijan, Georgia, and Tajikistan—faced such severe 
constraints on public spending on health during the 
1990s that their systems became highly dependent on 
private spending. The result has been an increase in 
health inequalities, with more  people impoverished 
through having to pay for health care. These coun-
tries face major challenges in meeting the objective 
of providing universal access to high quality primary 
healthcare services.9
The need to improve the performance of health 
systems and manage limited resources effectively 
is equally important in rich countries. A promising 
reform in Germany has seen the government provide 
insurers with financial incentives to enrol people with 
chronic disease into disease management programmes. 
In Switzerland, governance and funding have not been 
well aligned, and some cantonal governments have 
had to “rescue” loss making hospitals. Evidence from 
all countries reaffirms the importance of universal 
coverage, disease prevention and health promotion, 
organisational efficiency, high quality service delivery, 
and interventions aimed at tackling the social deter-
minants of health. For each of these, health systems 
should measure and aim to improve performance.
Adopting a wider approach to health requires strong, 
joined up government, which all countries—regardless 
of their state of development—struggle to achieve; 
as Wanless concluded, health policy remains stub-
bornly rooted in health care and in treating the sick. 
By introducing the “health in all policies” approach, 
the European Commission has sought to institution-
alise a wider approach to health in the development 
of public policy in all areas, including finance, agri-
culture, education, housing, transport, and the envi-
ronment.10 It is now mandatory to carry out health 
impact assessments in the course of developing new 
community policies. Evidence on the effect of health 
impact assessment is limited but suggests that it can 
be effective in influencing decisions in sectors outside 
health. A great deal depends on the seriousness with 
which it is taken by governments.11 A key message in 
the charter is that health ministers must assume a more 
active advocacy role in getting other ministers to take 
health seriously.
It is easy to be cynical about the value of gran-
diose pan-European charters and wrong to assume 
that economic development will inevitably improve 
health outcomes and reduce health inequities. 
The hope behind the Tallinn charter is that it will 
 galvanise the political will to develop more efficient 
and effective health systems, which are committed 
to narrowing Europe’s massive health and wealth 
divides.
All references are in the version on bmj.com
